Literature DB >> 2078322

Therapeutic considerations in the elderly hypertensive. The role of calcium channel blockers.

H R Black1.   

Abstract

Hypertension is an extremely common problem in the elderly. The optimum antihypertensive agent to use in this population is not certain. In this paper, the factors influencing the choice of antihypertensive therapy are reviewed. They include efficacy, safety, comorbidity, utility in special populations, drug interaction, dosage schedule, cost, the mechanisms of action of the drug, and the pathophysiology of the patient's hypertension. Calcium channel blockers are effective and safe in the elderly. They improve other conditions frequently seen in that population and, with the exception of cardiac conduction abnormalities associated with some calcium channel blockers, do not adversely affect other comorbid diseases. They work well together with other antihypertensives and as vasodilators, they may be specifically appropriate in elderly hypertensives, whose hypertension is associated with reduced cardiac output and increased peripheral vascular resistance. Once- and twice-a-day preparations are available to foster compliance, but calcium channel blockers are expensive.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2078322

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  4 in total

Review 1.  Pulse wave mechanics revisited: relevance to therapy of cardiovascular disease with calcium antagonists.

Authors:  M F O'Rourke
Journal:  Heart Vessels       Date:  1992       Impact factor: 2.037

2.  Self-Monitoring Home Blood Pressure in Community-Dwelling Older People: Age Differences in White-Coat and Masked Phenomena and Related Factors-The SONIC Study.

Authors:  Jinmei Tuo; Kayo Godai; Mai Kabayama; Yuya Akagi; Hiroshi Akasaka; Yoichi Takami; Yasushi Takeya; Koichi Yamamoto; Ken Sugimoto; Saori Yasumoto; Yukie Masui; Yasumichi Arai; Kazunori Ikebe; Yasuyuki Gondo; Tatsuro Ishizaki; Hiromi Rakugi; Kei Kamide
Journal:  Int J Hypertens       Date:  2022-04-30       Impact factor: 2.434

Review 3.  Insulin resistance and hypertension in the elderly. Optimal drug therapy.

Authors:  G Paolisso; A Gambardella; D Galzerano; M Varricchio
Journal:  Drugs Aging       Date:  1994-05       Impact factor: 3.923

Review 4.  ACE inhibitors. Differential use in elderly patients with hypertension.

Authors:  Z H Israili; W D Hall
Journal:  Drugs Aging       Date:  1995-11       Impact factor: 3.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.